Back to results
US 2020/0345753 A1Published application
Pharmaceutical compositions for the treatment of cancer
AssigneeTyme, Inc.
InventorSteven HOFFMAN
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods, compositions, and kits for treating cancer using a combination of L-rhamnose and a leucine aminopeptidase inhibitor.
Claims23
1-27. (canceled)
A method of treating cancer in a patient comprising administering to the patient a therapeutically effective amount of L-rhamnose and a therapeutically effective amount of a leucine aminopeptidase inhibitor.
A pharmaceutical composition comprising a therapeutically effective amount of L-rhamnose, a therapeutically effective amount of a leucine aminopeptidase inhibitor, and a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.